Can a trio of billionaires save American health care?
It has come to this
America's health-care system is a mess. Can three billionaires save it?
Jeff Bezos' Amazon (market capitalization: $693.2 billion), Warren Buffett's Berkshire Hathaway (market capitalization: $530.5 billion), and Jamie Dimon's JPMorgan Chase (market capitalization: $399.8 billion) are teaming up to create an independent company that will provide health care for the three mega-companies' roughly 1 million combined employees. Details remain sketchy. But the news still sent shockwaves through the market. Can these titans of finance and technology revolutionize the way Americans get health care?
We don't have much to go on so far. But it sounds like the new company would combine the functions of an insurer and a provider. Employees would either pay this new company premiums — or have the premiums taken out of their paychecks — and get health coverage from the same company in return.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Berkshire-Amazon-Chase wouldn't be the first to pursue this model. Kaiser Permanente does something similar. And CVS's recent purchase of Aetna points in that direction as well.
This model has a lot of potential. So much of our health-care system is fractured. We bounce between different primary-care doctors and specialists and insurance systems. They have to share information on our medical history, our care, our meds, and more. It's complicated and frustrating. Lots of things fall through the cracks.
Bringing the roles of insurance and care provision under the same roof allows for better coordination. "The initial focus of the new company will be on technology solutions that will provide U.S. employees and their families with simplified, high-quality, and transparent health care," as the press release said. You could imagine this leading to more preventative care, better treatment of chronic conditions, in-home and follow-up care, electronic record-keeping, user-friendly internet consultation, and more.
But would any of that actually lower the cost of care? For instance, despite how often it gets touted, there's not a lot of evidence that more preventative care would be a big money-saver.
That doesn't mean preventative care and the rest aren't worth pursuing. They'd lead to healthier Americans with better quality of life. It's just that talk around reforming costs often assumes that bad consumption habits are to blame. We use too much health care, or we use it poorly. There's some truth to this. But not enough to explain why America spends a vastly larger share of its GDP on health care for no discernible edge in outcomes.
The big problem with American health care is really prices. Compared to other countries, medical devices, drugs, and even doctors' pay are all super expensive in America. This is a failure of market leverage. Over the last few decades, providers have been able to bid these prices into the stratosphere, and no one's had the power to bid them back down. If Buffett, Bezos, and Dimon want to really fix American health care, they need to figure out how to lower prices — and better technology or coordination alone won't do it.
Berkshire Hathaway, Amazon, and JPMorgan Chase employ a combined one million people. That seems like a lot of customers — except that major insurers like UnitedHealth Group, Aetna, and Anthem already have customer bases that are many, many times larger. And they haven't been able to cut drug or device prices.
Theoretically, Bezos and Co.'s new group still should have enough scale to at least try and bargain down medical device and drug prices. The "everything in house" model might also help. The company could pay its doctors and providers on a salaried basis rather than a fee-for-service one, and they could expand into more use of nurse practitioners.
But there are limits. The country needs more doctors, and licensing can constrain the supply. That will put a real cap on how much Berkshire-Amazon-Chase can bargain down pay.
Lots of reports noted that the new health-care company will be nonprofit. That might help at the margins, but the real question remains whether it can find a way to control costs.
The underlying irony to all of this hubbub is that the very arguments being deployed in favor of this new health-care company are also the arguments for "big government" solutions. After all, if you want scale to negotiate prices, no one's bigger than the government bargaining for the entire American population.
But for the moment, big government solutions are off the table. Let's see what Buffett, Bezos, and Dimon can achieve by joining forces.
Create an account with the same email registered to your subscription to unlock access.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Jeff Spross was the economics and business correspondent at TheWeek.com. He was previously a reporter at ThinkProgress.
-
Liz Truss to save the West: is a political comeback really on the cards?
Talking Point The former prime minister is back with a new tell-all memoir
By Richard Windsor, The Week UK Published
-
Fallout: one of the 'most faithful – and best – video game adaptations'
The Week Recommends This 'genre-bending' new Amazon series is set in a post-apocalyptic wilderness where survivors shelter below ground
By Adrienne Wyper, The Week UK Published
-
'Test of faith for Trump Media's investors'
Today's Newspapers A roundup of the headlines from the US front pages
By The Week Staff Published
-
Arizona court reinstates 1864 abortion ban
Speed Read The law makes all abortions illegal in the state except to save the mother's life
By Rafi Schwartz, The Week US Published
-
Trump, billions richer, is selling Bibles
Speed Read The former president is hawking a $60 "God Bless the USA Bible"
By Peter Weber, The Week US Published
-
The debate about Biden's age and mental fitness
In Depth Some critics argue Biden is too old to run again. Does the argument have merit?
By Grayson Quay Published
-
How would a second Trump presidency affect Britain?
Today's Big Question Re-election of Republican frontrunner could threaten UK security, warns former head of secret service
By Harriet Marsden, The Week UK Published
-
'Rwanda plan is less a deterrent and more a bluff'
Instant Opinion Opinion, comment and editorials of the day
By The Week UK Published
-
Henry Kissinger dies aged 100: a complicated legacy?
Talking Point Top US diplomat and Nobel Peace Prize winner remembered as both foreign policy genius and war criminal
By Harriet Marsden, The Week UK Last updated
-
Trump’s rhetoric: a shift to 'straight-up Nazi talk'
Why everyone's talking about Would-be president's sinister language is backed by an incendiary policy agenda, say commentators
By The Week UK Published
-
More covfefe: is the world ready for a second Donald Trump presidency?
Today's Big Question Republican's re-election would be a 'nightmare' scenario for Europe, Ukraine and the West
By Sorcha Bradley, The Week UK Published